# MiNK Therapeutics, Inc.: Form DEF 14A, filed Apr 29, 2024

- Company: [MiNK Therapeutics, Inc.](/companies/inkt.md) (CIK 1840229)
- Form: DEF 14A
- Filed: 2024-04-29
- Accepted by EDGAR: Apr 29, 2024, 21:25 ET
- Period: 2023-12-31
- Accession: 0000950170-24-050064
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1840229/000095017024050064/2024_proxy.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1840229/000095017024050064/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1840229/000095017024050064/2024_proxy.htm

Filed Apr 29, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-050064. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.